AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30876469 — intervention group
Group type: COMPARATOR
Intervention: Standard GLB™ program + population-based lifestyle advice for weight management
Number of subjects: 0
Study 29935595 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (acustimulation/dexamethasone)
Number of subjects: 454
Study 29935595 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 454
Study 29935595 — intervention group
Group type: EXPERIMENTAL
Intervention: Acustimulation
Number of subjects: 454
Study 29935595 — intervention group
Group type: COMPARATOR
Intervention: Sham acustimulation/dexamethasone
Number of subjects: 454
Study 29935595 — intervention group
Group type: COMPARATOR
Intervention: Sham acustimulation/vehicle
Number of subjects: 454
Study 29935595 — intervention group
Group type: COMPARATOR
Intervention: Acustimulation/vehicle
Number of subjects: 454
Study 26679243 — intervention group
Group type: EXPERIMENTAL
Intervention: Delafloxacin (300 mg, intravenously, twice daily for 5-14 days)
Number of subjects: 256
Study 26679243 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (15 mg/kg, intravenously, twice daily for 5-14 days)
Number of subjects: 256
Study 26679243 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid (600 mg, intravenously, twice daily for 5-14 days)
Number of subjects: 256
Study 24563440 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 201
Study 24563440 — intervention group
Group type: COMPARATOR
Intervention: Normobaric oxygen therapy (NBOT)
Number of subjects: 201
Study 24563440 — intervention group
Group type: EXPERIMENTAL
Intervention: Troponin-I and CK-MB levels increase
Number of subjects: 201
Study 23098629 — intervention group
Group type: EXPERIMENTAL
Intervention: Pendular marking device
Number of subjects: 60
Study 23098629 — intervention group
Group type: EXPERIMENTAL
Intervention: Slitlamp marking device
Number of subjects: 60
Study 23098629 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble marking device
Number of subjects: 60
Study 23098629 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonometer marking device
Number of subjects: 60
Study 20619512 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal optimization of perioperative care
Number of subjects: 0
Study 17593070 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole granules (40 mg)
Number of subjects: 60
Study 17593070 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole tablets (40 mg)
Number of subjects: 60
Study 14976607 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel and mebendazole (treatment every 3 months)
Number of subjects: 317
Study 14976607 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 317
Study 11823735 — intervention group
Group type: EXPERIMENTAL
Intervention: Midnight removal of urinary catheters
Number of subjects: 160
Study 11823735 — intervention group
Group type: COMPARATOR
Intervention: 0600 hours removal of urinary catheters
Number of subjects: 160
Study 10404023 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of lactulose
Number of subjects: 12
Study 10404023 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of lactulose
Number of subjects: 12
Study 10404023 — intervention group
Group type: COMPARATOR
Intervention: Reference substance
Number of subjects: 12
Study 7751080 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric conditions (VO2maxnorm)
Number of subjects: 12
Study 7751080 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypobaric hypoxia (VO2maxhyp)
Number of subjects: 12
Study 7751080 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric conditions (VO2LTnorm)
Number of subjects: 12
Study 7751080 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypobaric hypoxia (VO2LThyp)
Number of subjects: 12
Study 7751080 — intervention group
Group type: COMPARATOR
Intervention: Hypobaric hypoxia
Number of subjects: 12
Study 2175022 — intervention group
Group type: EXPERIMENTAL
Intervention: New mixture of internal ester gangliosides
Number of subjects: 0
Study 2175022 — intervention group
Group type: COMPARATOR
Intervention: Traditional multi-vitamin treatment
Number of subjects: 0
Study 530565 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 39
Study 530565 — intervention group
Group type: COMPARATOR
Intervention: Untreated fellow eye
Number of subjects: 39
Study 30857489 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 168
Study 30994259 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard rehabilitation (SR) plus water rehabilitation (WR)
Number of subjects: 184
Study 30994259 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation (SR)
Number of subjects: 184
Study 28176290 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompted to explain each observation
Number of subjects: 3
Study 28176290 — intervention group
Group type: COMPARATOR
Intervention: Control condition (reporting the observation)
Number of subjects: 3
Study 25934044 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT-pyuria-based algorithm
Number of subjects: 125
Study 25934044 — intervention group
Group type: COMPARATOR
Intervention: Current guidelines (control group)
Number of subjects: 125
Study 24224521 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bolus of tenecteplase
Number of subjects: 87
Study 24224521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 21317197 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot program addressing childhood obesity with behavioral modification
Number of subjects: 68
Study 21317197 — intervention group
Group type: COMPARATOR
Intervention: Matched control group
Number of subjects: 68
Study 19477404 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha(2C) Del322-325 polymorphism
Number of subjects: 526
Study 19477404 — intervention group
Group type: EXPERIMENTAL
Intervention: beta(1) Arg389Gly polymorphism
Number of subjects: 526
Study 17416851 — intervention group
Group type: EXPERIMENTAL
Intervention: Two CT scans at 3 and 12 months
Number of subjects: 414
Study 17416851 — intervention group
Group type: COMPARATOR
Intervention: Five CT scans at 3, 6, 9, 12, and 24 months
Number of subjects: 414
Study 15058698 — intervention group
Group type: EXPERIMENTAL
Intervention: +1.00 add power
Number of subjects: 20
Study 15058698 — intervention group
Group type: EXPERIMENTAL
Intervention: +1.50 add power
Number of subjects: 20
Study 15058698 — intervention group
Group type: EXPERIMENTAL
Intervention: +2.00 add power
Number of subjects: 20
Study 15058698 — intervention group
Group type: EXPERIMENTAL
Intervention: +2.50 add power
Number of subjects: 20
Study 15879864 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin plus behavior modification
Number of subjects: 25
Study 15879864 — intervention group
Group type: COMPARATOR
Intervention: Behavior modification alone
Number of subjects: 25
Study 10359410 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly isoniazid (900 mg) and rifapentine (600 mg)
Number of subjects: 71
Study 10359410 — intervention group
Group type: COMPARATOR
Intervention: Twice-weekly isoniazid (900 mg) and rifampin (600 mg)
Number of subjects: 71
Study 8961309 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice of throwing skill from one position (sitting on a Balans chair)
Number of subjects: 40
Study 8961309 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice of throwing skill from one position (reclined on a slanted table)
Number of subjects: 40
Study 8961309 — intervention group
Group type: COMPARATOR
Intervention: No practice (control group)
Number of subjects: 40
Study 1850691 — intervention group
Group type: EXPERIMENTAL
Intervention: Beet fiber supplementation (16 g added to ordinary diet)
Number of subjects: 13
Study 1850691 — intervention group
Group type: EXPERIMENTAL
Intervention: Beet fiber supplementation
Number of subjects: 13
Study 6121836 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam (6 mg daily: 1.5 mg at 7 a.m., 1.5 mg at 3 p.m., 3 mg at 11 p.m.)
Number of subjects: 33
Study 6121836 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same dosage pattern as bromazepam)
Number of subjects: 33
Study 30930141 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Block (ESB)
Number of subjects: 60
Study 30930141 — intervention group
Group type: COMPARATOR
Intervention: Serratus Plane Block (SPB)
Number of subjects: 60
Study 28778254 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% dextrose (D5W)
Number of subjects: 49
Study 28778254 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 49
Study 25906786 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Glucose Tolerance (NGT)
Number of subjects: 1376
Study 25906786 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediabetes
Number of subjects: 1376
Study 25906786 — intervention group
Group type: EXPERIMENTAL
Intervention: Any dysglycemia
Number of subjects: 1376
Study 25906786 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 1376
Study 23054802 — intervention group
Group type: EXPERIMENTAL
Intervention: CR-I (60:40 roughage-to-concentrate ratio)
Number of subjects: 24
Study 23054802 — intervention group
Group type: EXPERIMENTAL
Intervention: CR-II (50:50 roughage-to-concentrate ratio)
Number of subjects: 24
Study 23054802 — intervention group
Group type: EXPERIMENTAL
Intervention: CR-III (40:60 roughage-to-concentrate ratio)
Number of subjects: 24
Study 23054802 — intervention group
Group type: EXPERIMENTAL
Intervention: CR-IV (30:70 roughage-to-concentrate ratio)
Number of subjects: 24
Study 23054802 — intervention group
Group type: COMPARATOR
Intervention: CR-IV and CR-III
Number of subjects: 24
Study 23054802 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 24
Study 22219537 — intervention group
Group type: EXPERIMENTAL
Intervention: Game activity for studying course material
Number of subjects: 2
Study 22219537 — intervention group
Group type: COMPARATOR
Intervention: No-game condition
Number of subjects: 2
Study 19725291 — intervention group
Group type: COMPARATOR
Intervention: Southern states patients
Number of subjects: 2025
Study 19725291 — intervention group
Group type: COMPARATOR
Intervention: Northern states patients
Number of subjects: 2025
Study 17694232 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia CD (MCD) presented by Registered Nurse (RN) in Group A (n = 15)
Number of subjects: 60
Study 17694232 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet information in Group B (n = 15)
Number of subjects: 60
Study 17694232 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal information from RN in Group C (n = 15)
Number of subjects: 60
Study 17694232 — intervention group
Group type: COMPARATOR
Intervention: Conventional information by attending surgeon and anesthesiologist in Control Group D (n = 15)
Number of subjects: 60
Study 15155303 — intervention group
Group type: EXPERIMENTAL
Intervention: IA saline 10 mL
Number of subjects: 60
Study 15155303 — intervention group
Group type: COMPARATOR
Intervention: IA saline 1 mL (placebo)
Number of subjects: 60
Study 11463597 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol Turbohaler 9 microg
Number of subjects: 12
Study 11463597 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 200 microg
Number of subjects: 12
Study 11463597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9886506 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg leuprolide acetate (GnRHa) for ovulation induction
Number of subjects: 26
Study 9886506 — intervention group
Group type: COMPARATOR
Intervention: Human chorionic gonadotrophin (HCG) 10,000 IU i.m. for ovulation induction
Number of subjects: 26
Study 8294618 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg q.d.
Number of subjects: 19
Study 8294618 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg b.i.d.
Number of subjects: 19
Study 8294618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 30289327 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic surgery (RALS)
Number of subjects: 120
Study 30289327 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy (LT)
Number of subjects: 120
Study 30289327 — intervention group
Group type: EXPERIMENTAL
Intervention: EuroQol Eq5D
Number of subjects: 120
Study 27307362 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-Midvastus (MMV) approach
Number of subjects: 97
Study 27307362 — intervention group
Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 97
Study 25638572 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia (3.5%)
Number of subjects: 42
Study 25638572 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anesthesia (1.0%)
Number of subjects: 42
Study 23622917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial contrast injection
Number of subjects: 170
Study 23622917 — intervention group
Group type: COMPARATOR
Intervention: Intravenous contrast administration
Number of subjects: 170
Study 20639734 — intervention group
Group type: EXPERIMENTAL
Intervention: Naprapathic manual therapy
Number of subjects: 78
Study 20639734 — intervention group
Group type: COMPARATOR
Intervention: Conventional orthopedic care
Number of subjects: 78
Study 18469237 — intervention group
Group type: EXPERIMENTAL
Intervention: C12 (lauric acid)
Number of subjects: 13
Study 18469237 — intervention group
Group type: EXPERIMENTAL
Intervention: C18 (oleic acid)
Number of subjects: 13
Study 18469237 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 13
Study 16968504 — intervention group
Group type: EXPERIMENTAL
Intervention: IV pantoprazole (PAN) 80 mg plus 8 mg/h for 72 h
Number of subjects: 149
Study 16968504 — intervention group
Group type: COMPARATOR
Intervention: IV ranitidine (RAN) 50 mg plus 6.25 mg/h for 72 h
Number of subjects: 149
Study 14586600 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate
Number of subjects: 34
Study 14586600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 11107929 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 36
Study 11107929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 9108644 — intervention group
Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl (8 mg)
Number of subjects: 20
Study 9108644 — intervention group
Group type: EXPERIMENTAL
Intervention: Biperiden (6 mg)
Number of subjects: 20
Study 9108644 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 20
Study 8099803 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol, 100 mg once daily
Number of subjects: 34
Study 8099803 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol, 50 mg three times daily
Number of subjects: 34
Study 8099803 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, single 40 mg dose
Number of subjects: 34
Study 2869703 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate infusions
Number of subjects: 25
Study 2869703 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic alprazolam treatment
Number of subjects: 25
Study 2869703 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusions
Number of subjects: 25
Study 31362262 — intervention group
Group type: EXPERIMENTAL
Intervention: EIMD group received a treatment to induce muscle damage consisting of a weight lifting protocol directed to the agonist muscles related to the task prior to the pretest and to the learning sessions.
Number of subjects: 30
Study 31362262 — intervention group
Group type: COMPARATOR
Intervention: CON group (control group) did not receive the EIMD treatment.
Number of subjects: 30
Study 30218170 — intervention group
Group type: EXPERIMENTAL
Intervention: Home intravenous (IV) ertapenem
Number of subjects: 82
Study 30218170 — intervention group
Group type: COMPARATOR
Intervention: Oral amoxicillin‐clavulanate
Number of subjects: 82
Study 26368863 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 0
Study 26368863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26368863 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment responders
Number of subjects: 0
Study 25320894 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based training system for CHAs; 13 training videos, average completion time of 26 days.
Number of subjects: 12
Study 25320894 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of cancer early detection workshops by trained CHAs.
Number of subjects: 12
Study 22585642 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (Cytotec ®)
Number of subjects: 300
Study 22585642 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone (Prépidil ®)
Number of subjects: 300
Study 20187985 — intervention group
Group type: EXPERIMENTAL
Intervention: High total meat consumption
Number of subjects: 24845
Study 20187985 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed meat consumption
Number of subjects: 24845
Study 20187985 — intervention group
Group type: COMPARATOR
Intervention: Red meat and poultry consumption
Number of subjects: 24845
Study 18309301 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet intervention (n=66)
Number of subjects: 135
Study 18309301 — intervention group
Group type: COMPARATOR
Intervention: Self-directed weight maintenance (n=69)
Number of subjects: 135
Study 16044981 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care intervention group
Number of subjects: 2242
Study 16044981 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 2242
Study 11817499 — intervention group
Group type: EXPERIMENTAL
Intervention: HUFA supplementation
Number of subjects: 41
Study 11817499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 9922346 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (1.5 x 10^6 U over 30 to 60 minutes)
Number of subjects: 251
Study 7547516 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive management aimed at cure
Number of subjects: 0
Study 7547516 — intervention group
Group type: COMPARATOR
Intervention: Expectant medical management ('watchful waiting')
Number of subjects: 0
Study 2281830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine plus bicarbonate
Number of subjects: 28
Study 2281830 — intervention group
Group type: COMPARATOR
Intervention: Plain lidocaine
Number of subjects: 28
Study 442224 — intervention group
Group type: EXPERIMENTAL
Intervention: peptichemio at 1.2 mg/kg twice weekly
Number of subjects: 32
Study 442224 — intervention group
Group type: EXPERIMENTAL
Intervention: peptichemio at 0.9 mg/kg twice weekly
Number of subjects: 32
Study 442224 — intervention group
Group type: EXPERIMENTAL
Intervention: peptichemio at 1.3 mg/kg once weekly combined with other cytostatic drugs
Number of subjects: 32
Study 31927349 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise (EE) program plus vibration for 12 weeks
Number of subjects: 61
Study 31927349 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercise (EE) program plus cryotherapy for 12 weeks
Number of subjects: 61
Study 30882563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI) at 13 ± 1° C for 15 minutes
Number of subjects: 64
Study 30882563 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery for 15 minutes
Number of subjects: 64
Study 27667324 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 16
Study 27667324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 27265706 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle coaching plus care coordination plus treatment as usual (N=138)
Number of subjects: 428
Study 27265706 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordination plus treatment as usual (N=142)
Number of subjects: 428
Study 27265706 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual alone (N=148)
Number of subjects: 428
Study 25124733 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin-contained red pepper sauce (acute infusion)
Number of subjects: 15
Study 25124733 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin-contained red pepper sauce (repeated infusion)
Number of subjects: 15
Study 25124733 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15
Study 21921823 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐nitrooxy ethyl 2‐amino 3‐methylbutanoate gel
Number of subjects: 14
Study 21921823 — intervention group
Group type: COMPARATOR
Intervention: Placebo (tea tree oil)
Number of subjects: 14
Study 19152118 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamically Modified Outcomes (DYNAMO)
Number of subjects: 0
Study 17472154 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed intravenous fluids using a dry IV fluid warmer (normothermia group)
Number of subjects: 60
Study 17472154 — intervention group
Group type: COMPARATOR
Intervention: Room temperature intravenous fluids (hypothermia group)
Number of subjects: 60
Study 16388166 — intervention group
Group type: EXPERIMENTAL
Intervention: McCoy laryngoscope and fentanyl
Number of subjects: 180
Study 16388166 — intervention group
Group type: EXPERIMENTAL
Intervention: McCoy laryngoscope and no fentanyl
Number of subjects: 180
Study 16388166 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope and fentanyl
Number of subjects: 180
Study 16388166 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope and no fentanyl
Number of subjects: 180
Study 11991773 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise physiology program (theory + active aerobic and resistance exercise)
Number of subjects: 161
Study 11991773 — intervention group
Group type: COMPARATOR
Intervention: Standard biology course (control group)
Number of subjects: 161
Study 9861410 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of quinine (20 mg/kg)
Number of subjects: 113
Study 9861410 — intervention group
Group type: COMPARATOR
Intervention: No loading dose of quinine
Number of subjects: 113
Study 8556417 — intervention group
Group type: EXPERIMENTAL
Intervention: ASMT 1 (1 hour a week)
Number of subjects: 22000
Study 8556417 — intervention group
Group type: EXPERIMENTAL
Intervention: ASMT 2 (3 hours a week)
Number of subjects: 22000
Study 8556417 — intervention group
Group type: EXPERIMENTAL
Intervention: ASMT 3 (competitors)
Number of subjects: 22000
Study 8556417 — intervention group
Group type: COMPARATOR
Intervention: Sedentary group
Number of subjects: 22000